Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis

J Matern Fetal Neonatal Med. 2018 Jan;31(2):258-260. doi: 10.1080/14767058.2016.1277703. Epub 2017 Jan 23.

Abstract

Purpose: To evaluate the levels of peripheral blood CD34+ cells in women who subsequently had a spontaneous miscarriage (SM).

Materials and methods: We enrolled 11 women who had SM, matching them for age, BMI and gestational age with 33 healthy pregnancies (controls). From a blood sample at 9th-11th weeks of pregnancy, we evaluated PAPP-A, free β-hCG, T (suppressor and helper), NK, B, CD34+ cells.

Results: In peripheral blood of women who had SM, PAPP-A and CD34+ cells were significantly lower (p < 0.001) compared to control group.

Conclusions: CD34+ cell low level in peripheral blood is associated with increased risk of SM.

Keywords: CD34; Hematopoietic stem cells; first trimester; miscarriage; peripheral blood.

MeSH terms

  • Abortion, Spontaneous / blood*
  • Adult
  • Antigens, CD34 / blood*
  • Biomarkers / blood*
  • Case-Control Studies
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Trimester, First / blood*
  • Pregnancy-Associated Plasma Protein-A / analysis*
  • Young Adult

Substances

  • Antigens, CD34
  • Biomarkers
  • Pregnancy-Associated Plasma Protein-A